Ticker > Company >

Cravatex share price

Cravatex Ltd.

BSE: 509472 SECTOR: Trading  10k   13   0

480.00
+8.40 (1.78%)
BSE: 20 Dec 04:01 PM

Price Summary

Today's High

₹ 508

Today's Low

₹ 468.25

52 Week High

₹ 686.5

52 Week Low

₹ 351

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

124.04 Cr.

Enterprise Value

120.8 Cr.

No. of Shares

0.26 Cr.

P/E

30.87

P/B

6.5

Face Value

₹ 10

Div. Yield

0.63 %

Book Value (TTM)

₹  73.8

CASH

3.24 Cr.

DEBT

0 Cr.

Promoter Holding

75 %

EPS (TTM)

₹  15.55

Sales Growth

-46.26%

ROE

22.31 %

ROCE

23.72%

Profit Growth

113.04 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Cravatex Ltd.

Proline Fitness Johson Horizon Matrix FILA

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-46.26%
3 Year-6.75%
5 Year12.47%

Profit Growth

1 Year113.04%
3 Year-15.03%
5 Year9.34%

ROE%

1 Year22.31%
3 Year-21%
5 Year-7.95%

ROCE %

1 Year23.72%
3 Year-16.82%
5 Year-4.86%

Debt/Equity

0

Price to Cash Flow

-50.45

Interest Cover Ratio

9.2226

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 75.00 0.00
Jun 2024 75.00 0.00
Mar 2024 75.00 0.00
Dec 2023 75.00 0.00
Sep 2023 75.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • Company’s PEG ratio is 0.27310720991896.
  • The company has an efficient Cash Conversion Cycle of -12.8002 days.
  • Company has a healthy liquidity position with current ratio of 7.5242.
  • The company has a high promoter holding of 75%.

 Limitations

  • The company has shown a poor profit growth of -15.0250423709864% for the Past 3 years.
  • The company has shown a poor revenue growth of -6.75065433216932% for the Past 3 years.
  • Company has a poor ROE of -21.0013087178217% over the past 3 years.
  • Company has a poor ROCE of -16.822620431112% over the past 3 years
  • Company has negative cash flow from operations of -2.4586.
  • Tax rate is low at -5.489.
  • The company has a low EBITDA margin of -103.697697572981% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Net Sales 0.92 0 0.96 0 2.26
Total Expenditure 1.53 0.62 1.48 0.55 2.87
Operating Profit -0.61 -0.62 -0.53 -0.55 -0.61
Other Income 1.27 2.41 1.27 1.24 3.46
Interest 0.08 0.13 0.11 0.11 0.11
Depreciation 0.36 0.38 0.29 0.26 0.26
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.22 1.28 0.34 0.32 2.48
Tax -0.73 0.37 -0.37 0.03 0.37
Profit After Tax 0.94 0.91 0.71 0.29 2.11
Adjusted EPS (Rs) 3.64 3.52 2.76 1.12 8.15

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 2.42 2.31 2.44 3.48 1.87
Total Expenditure 5.33 4.74 4.67 6.24 4.16
Operating Profit -2.91 -2.44 -2.23 -2.76 -2.29
Other Income 7.11 10.02 8.76 9.89 7.39
Interest 0.81 0.66 0.74 1.38 0.41
Depreciation 0.85 0.74 0.7 0.81 1.34
Exceptional Items 0 0 0 -32.72 0
Profit Before Tax 2.55 6.19 5.1 -27.78 3.35
Tax 0.23 0.42 0.71 -0.64 -0.18
Net Profit 2.32 5.77 4.39 -27.14 3.54
Adjusted EPS (Rs.) 8.98 22.31 16.98 -105.03 13.69

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 2.58 2.58 2.58 2.58 2.58
Total Reserves 30.49 35.98 39.59 11.68 14.87
Borrowings 3.89 3.99 4.02 0 0
Other N/C liabilities 4.47 5.91 4.33 1.27 2.79
Current liabilities 3.96 2.34 3.33 3.91 1.68
Total Liabilities 45.4 50.81 53.85 19.44 21.92
Assets
Net Block 1.91 2.17 1.65 2.42 3.64
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 39.54 39.37 43.13 0.42 0.42
Loans & Advances 0.22 0.44 1.44 2.58 0.46
Other N/C Assets 0 0 6.08 4.97 4.78
Current Assets 3.74 8.83 1.55 9.04 12.62
Total Assets 45.4 50.81 53.85 19.44 21.92
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 2.55 6.19 5.1 -27.78 3.35
Adjustment -4.1 -7.14 -6.62 24.9 -6.11
Changes in Assets & Liabilities 0.03 -0.4 -1.1 -1.96 0.69
Tax Paid -0.52 -0.67 -0.6 -0.35 -0.39
Operating Cash Flow -2.04 -2.02 -3.23 -5.18 -2.46
Investing Cash Flow 5.12 3.63 5.27 16.05 0.29
Financing Cash Flow -3.77 -1.23 -1.67 -8.36 -0.39
Net Cash Flow -0.7 0.38 0.37 2.51 -2.56

Corporate Actions

Investors Details

PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
promoters 75.00 75.00 75.00 75.00 75.00
prathima batra 0.63 0.63 0.63 0.63 0.63
r b fitness and trading p... 74.36 74.36 74.36 74.36 74.36
PARTICULARS Sep 2023% Dec 2023% Mar 2024% Jun 2024% Sep 2024%
investors 25.00 25.00 25.00 25.00 25.00
investor education and pr... 1.77 1.77 1.77 1.77 1.77
llp - - 0.02 0.02 0.04
mahendra girdharilal wadh... 1.83 1.83 1.83 1.83 1.83
mahesh parameswaran nair 2.01 2.01 2.01 2.01 2.01
neka dipak shah 1.01 1.01 1.01 1.01 1.01
rhea dipak shah 1.01 1.01 1.01 1.01 1.01
shashank s khade 1.64 1.51 1.20 1.20 1.20

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Cravatex informs about loss of share certificate 18 Sep, 4:35 PM Cravatex informs about loss of share certificate 18 Sep, 12:12 PM Cravatex informs about details of loss of certificate 2 Sep, 4:36 PM Cravatex - Quaterly Results 12 Aug, 4:56 PM Cravatex - Quaterly Results 12 Aug, 4:56 PM Cravatex informs about loss of share certificate 24 Jul, 12:04 PM Cravatex - Quaterly Results 24 May, 6:26 PM Cravatex - Quaterly Results 24 May, 6:26 PM Cravatex informs about compliance certificate 5 Apr, 3:46 PM Cravatex - Quaterly Results 14 Feb, 4:43 PM Cravatex - Quaterly Results 14 Feb, 4:43 PM Cravatex informs about loss of share certificate(s) 7 Nov, 11:33 AM Cravatex informs about loss of share certificate 10 Oct, 2:15 PM Cravatex informs about loss of share certificate 21 Sep, 12:18 PM Cravatex informs about book closure 27 May, 3:36 PM Cravatex informs about PCS certificate 28 Apr, 1:01 PM Cravatex informs about compliance certificate 11 Apr, 4:28 PM Cravatex - Quaterly Results 13 Feb, 6:20 PM Cravatex informs about redemption of preference shares 11 Jan, 5:19 PM Cravatex informs about loss of share certificate 9 Dec, 4:09 PM Cravatex completes sale of 100% shareholding held in Cravatex Brands 5 Dec, 9:40 AM Cravatex informs about related party transactions 26 Nov, 2:26 PM Cravatex gets nod to sell 100% stake in Cravatex Brands 20 Oct, 9:46 AM Cravatex informs about details of loss of certificate 4 Oct, 3:17 PM Cravatex informs about trading window closure 29 Sep, 3:05 PM Cravatex informs about loss of share certificates 14 Sep, 9:30 AM Cravatex informs about compliances-certificate 8 Jul, 12:44 PM Cravatex informs about newspaper cutting 10 Jun, 5:11 PM Cravatex informs about closure of trading window 29 Mar, 4:11 PM Cravatex informs about loss of share certificates 16 Feb, 12:01 PM Cravatex informs about loss of share certificates 16 Feb, 9:59 AM Cravatex informs about board meeting 5 Feb, 11:36 AM Cravatex informs about loss of share certificates 18 Dec, 11:26 AM Cravatex informs about board meeting 1 Nov, 4:13 PM Cravatex informs about AGM proceedings 28 Aug, 11:06 AM Cravatex’s arm incorporates WoS in Germany 13 Feb, 9:37 AM Cravatex informs about board meeting 4 Feb, 3:44 PM

Cravatex Stock Price Analysis and Quick Research Report. Is Cravatex an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Cravatex stock price today is Rs 480. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Cravatex . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Cravatex has a PE ratio of 30.8709465803995 which is high and comparatively overvalued .

  • Share Price: - The current share price of Cravatex is Rs 480. One can use valuation calculators of ticker to know if Cravatex share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Cravatex has ROA of 17.1114 % which is a good sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Cravatex has a Current ratio of 7.5242 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Cravatex has a ROE of 22.3121 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Cravatex has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Cravatex has reported revenue growth of -46.2575 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Cravatex for the current financial year is -122.2810111699 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Cravatex is Rs 3 and the yield is 0.625 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Cravatex is Rs 15.5486 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Cravatex in Ticker for free. Also, one can get the intrinsic value of Cravatex by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Cravatex
X